Suzhou Yilian Biopharmaceutical Co.
Latest round
- Series B
Last raised
- Mar 2022
Total raised
- $70M
Investors
- 6
About Suzhou Yilian Biopharmaceutical Co.
, Ltd. is a biopharmaceutical company that focuses on research, development and manufacturing next-generation antibody-coupled drugs. The CSO Dr. Jiaqiang Cai has nearly 30 years of experience in small molecule and coupling technology development and has served as Vice President of Shanghai Hansen Pharmaceuticals. The CEO Dr. Tongtong Xue serves as general manager in Kelun Botai. The company's main business is medical research and experimental development, health consulting services ,and research and development of next-generation antibody-coupled drugs. The products used in the field of leukemia, lymphoma, breast cancer and multiple myeloma.
Who invested in Suzhou Yilian Biopharmaceutical Co.
6 investors across 3 rounds
See all investors in Suzhou Yilian Biopharmaceutical Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Suzhou Yilian Biopharmaceutical Co.
Who invested in Suzhou Yilian Biopharmaceutical Co.?
Suzhou Yilian Biopharmaceutical Co. has 6 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Suzhou Yilian Biopharmaceutical Co. raised?
Suzhou Yilian Biopharmaceutical Co. has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Suzhou Yilian Biopharmaceutical Co. last raise money?
Suzhou Yilian Biopharmaceutical Co.'s most recent round on record is a Series B, in Mar 2022.
What does Suzhou Yilian Biopharmaceutical Co. do?
Suzhou Yilian Biopharmaceutical Co. is a biotechnology company.
Where is Suzhou Yilian Biopharmaceutical Co. headquartered?
Suzhou Yilian Biopharmaceutical Co. is headquartered in Suzhou, China.
Which VCs invest in companies like Suzhou Yilian Biopharmaceutical Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at Suzhou Yilian Biopharmaceutical Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Suzhou Yilian Biopharmaceutical Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.